Comparison 8. Methylprednisolone versus dexamethasone for hospitalised individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
8.1 All‐cause mortality up to 30 days | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |